Prostate cancer is the most prevalent solid tumor diagnosed
in men in developed countries. The standard treatment for early stage prostate
cancer is surgery (prostatectomy) or radiotherapy. To improve local control,
the radiation dose should be escalated. Threedimensional conformal radiation
treatment (3DCRT) increases local control rates while decreasing toxicity
rates.
Recent data suggest that, to achieve high local control of
prostate cancer with acceptable toxicity, hypofractionated radiotherapy (HRT) could be used. Short-duration
HRT is an attractive option compared with a 7-to-8-week course of standard
radiotherapy in terms of logistics the patient’s job, daily activities, and
emotions; the availability of accelerators, and the cost of prolonged
treatment.
Quality of life (QoL) has become one of the most significant
issues in treatment decisions in prostate cancer. In the case of QoL
measurement after radical prostatectomy, brachytherapy, or external beam
radiotherapy, all types of prostate cancer treatment were shown to be
associated with changes in the QoL domains related to urinary, bowel, and
sexual functions.
No comments:
Post a Comment